215 related articles for article (PubMed ID: 38791464)
1. Systematic Review of Genetic Modifiers Associated with the Development and/or Progression of Nephropathy in Patients with Sickle Cell Disease.
Labarque V; Okocha EC;
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791464
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy.
Garrett ME; Soldano KL; Erwin KN; Zhang Y; Gordeuk VR; Gladwin MT; Telen MJ; Ashley-Koch AE
Blood Adv; 2023 Sep; 7(17):4782-4793. PubMed ID: 36399516
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
Adebayo OC; Betukumesu DK; Nkoy AB; Adesoji OM; Ekulu PM; Van den Heuvel LP; Levtchenko EN; Labarque V
Br J Haematol; 2022 Jan; 196(1):204-214. PubMed ID: 34545573
[TBL] [Abstract][Full Text] [Related]
4. Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia.
Schaefer BA; Flanagan JM; Alvarez OA; Nelson SC; Aygun B; Nottage KA; George A; Roberts CW; Piccone CM; Howard TA; Davis BR; Ware RE
PLoS One; 2016; 11(10):e0164364. PubMed ID: 27711207
[TBL] [Abstract][Full Text] [Related]
5. The nephropathy of sickle cell trait and sickle cell disease.
Ataga KI; Saraf SL; Derebail VK
Nat Rev Nephrol; 2022 Jun; 18(6):361-377. PubMed ID: 35190716
[TBL] [Abstract][Full Text] [Related]
6. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.
Geard A; Pule GD; Chetcha Chemegni B; Ngo Bitoungui VJ; Kengne AP; Chimusa ER; Wonkam A
Br J Haematol; 2017 Aug; 178(4):629-639. PubMed ID: 28466968
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy.
Saraf SL; Zhang X; Shah B; Kanias T; Gudehithlu KP; Kittles R; Machado RF; Arruda JA; Gladwin MT; Singh AK; Gordeuk VR
Haematologica; 2015 Oct; 100(10):1275-84. PubMed ID: 26206798
[TBL] [Abstract][Full Text] [Related]
9. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
10. Sickle Cell Disease and CKD: An Update.
Zahr RS; Saraf SL
Am J Nephrol; 2024; 55(1):56-71. PubMed ID: 37899028
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.
Kaspar CDW; Beach I; Newlin J; Sisler I; Feig D; Smith W
Pediatr Nephrol; 2020 May; 35(5):883-889. PubMed ID: 31960140
[TBL] [Abstract][Full Text] [Related]
12. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
[TBL] [Abstract][Full Text] [Related]
13. Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.
Derebail VK; Ciccone EJ; Zhou Q; Kilgore RR; Cai J; Ataga KI
Am J Kidney Dis; 2019 Jul; 74(1):47-55. PubMed ID: 30797615
[TBL] [Abstract][Full Text] [Related]
14. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.
Aygun B; Mortier NA; Smeltzer MP; Hankins JS; Ware RE
Pediatr Nephrol; 2011 Aug; 26(8):1285-90. PubMed ID: 21559933
[TBL] [Abstract][Full Text] [Related]
15. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
16. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
17. Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.
Lebensburger JD; Aban I; Pernell B; Kasztan M; Feig DI; Hilliard LM; Askenazi DJ
Am J Hematol; 2019 Apr; 94(4):417-423. PubMed ID: 30592084
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.
Naik RP; Derebail VK
Expert Rev Hematol; 2017 Dec; 10(12):1087-1094. PubMed ID: 29048948
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.
Belisário AR; da Silva AA; Silva CV; de Souza LM; Wakabayashi EA; Araújo SA; Simoes-E-Silva AC
Biomark Med; 2019 Aug; 13(11):967-987. PubMed ID: 31390894
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
Derebail VK; Zhou Q; Ciccone EJ; Cai J; Ataga KI
Br J Haematol; 2021 Oct; 195(1):123-132. PubMed ID: 34402052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
